MEDPAL AI is trading at £5.40, down -10.03%, after announcing a £5 million placing at 5.0 pence per share.
- The fundraising issues 100 million new shares and supports working capital.
- September annualised revenue reached £35 million, up from £28 million in August.
- Investors appear focused on dilution and funding needs as the broader market rises, making company-specific financing the clearest catalyst.